Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Specific Membrane Antigen”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04599699
What this trial is testing

Integrated Boost to the Dominant Intraprostatic Nodule Based on Ga-68 PSMA PET/MR Study of SBRT With Prostate Cancer

Who this might be right for
Treatment
Changhai Hospital 20
Early research (Phase 1)Active Not RecruitingNCT06379217
What this trial is testing

NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer.

Who this might be right for
Metastatic Neuroendocrine Prostate Cancer
Novartis Pharmaceuticals 31
Not applicableEnded earlyNCT05208229
What this trial is testing

The Role of WB-MRI in the Evaluation of Prostate Cancer Patients Treated With Lutetium - Prostate Specific Membrane Antigen (Lu-PSMA)

Who this might be right for
Metastatic Castration Resistant Prostate Cancer (mCRPC)
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 2
Early research (Phase 1)Looking for participantsNCT06943495
What this trial is testing

Personalized vs. Fixed-Activity 177Lu-PSMA-617 Radiopharmaceutical Therapy (PRODIGY-2)

Who this might be right for
Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Jean-Mathieu Beauregard 60
Early research (Phase 1)Study completedNCT02916537
What this trial is testing

Trial for Evaluation of the Safety, Pharmacokinetics, and [18F] Radiation Dosimetry of CTT1057

Who this might be right for
Prostate Cancer
Cancer Targeted Technology 20
Not applicableStudy completedNCT02978586
What this trial is testing

A Pilot Study of [Ga-68]PSMA PET/MRI for the Assessment of PSMA-positive Tumors

Who this might be right for
Prostate-specific Membrane Antigen Positive TumorsProstate CancerBreast Cancer+1 more
Case Comprehensive Cancer Center 8
Testing effectiveness (Phase 2)Looking for participantsNCT06970119
What this trial is testing

A Multicenter, Open-label, Non-randomized Phase I/IIa Clinical Trial to Evaluate INR102 Injection in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Yunhe Pharmaceutical (Tianjin) Co., Ltd 55
Testing effectiveness (Phase 2)Ended earlyNCT04631601
What this trial is testing

Safety and Efficacy of Therapies for Metastatic Castration-resistant Prostate Cancer (mCRPC)

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Amgen 55
Not applicableLooking for participantsNCT06866782
What this trial is testing

European Registry of Next Generation Imaging in Advanced Prostate Cancer

Who this might be right for
Prostate CancerAdvanced Prostate CancerMetastatic Prostate Cancer (mPC)
Fundacio Puigvert 600
Early research (Phase 1)UnknownNCT04839991
What this trial is testing

Study of CB307 in Patients With Advanced and/or Metastatic PSMA-positive Tumours.

Who this might be right for
Advanced and/or Metastatic Solid Tumours
Crescendo Biologics Ltd. 70
Not applicableUnknownNCT03507595
What this trial is testing

Evaluation of the Metastasis and Recurrence of Prostate Cancer

Who this might be right for
Prostate Cancer (Diagnosis)Prostate Cancer MetastaticProstate Cancer Recurrent+1 more
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 400
Early research (Phase 1)Study completedNCT00096629
What this trial is testing

Vaccine Therapy in Treating Patients With Kidney Cancer

Who this might be right for
Kidney Cancer
Memorial Sloan Kettering Cancer Center 15
Early research (Phase 1)Study completedNCT01359189
What this trial is testing

Evaluation of a Transrectal Scintigraphic Detector(ProxiScanTM) for Detection of Primary Prostate Cancer

Who this might be right for
Suspected Primary Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 4
Not applicableUnknownNCT06201741
What this trial is testing

Evaluate the Human Biodistribution and Dosimetry of the Radionuclide Labeled ZT-111 in Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Specific Membrane Antigen Positive Metastatic Prostate Cancer
Huashan Hospital 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT05849298
What this trial is testing

A Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With PSMA PET Scan Positive CRPC

Who this might be right for
Prostatic Neoplasm
Novartis Pharmaceuticals 49
Early research (Phase 1)UnknownNCT05902247
What this trial is testing

Actium-225-Prostate Specific Membrane Antigen Imaging & Therapy

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Erasmus Medical Center 30
Not applicableStudy completedNCT05022576
What this trial is testing

Robotic-arm Assisted Ga-68 PSMA PET/CT Guided Transgluteal Prostate Biopsy

Who this might be right for
Prostate Cancer
Post Graduate Institute of Medical Education and Research, Chandigarh 78
Early research (Phase 1)Looking for participantsNCT07082920
What this trial is testing

JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Janssen Research & Development, LLC 140
Large-scale testing (Phase 3)Looking for participantsNCT07052214
What this trial is testing

PSMA PET Combined With MRI for the Detection of PCa

Who this might be right for
PCAProstate CancerProstatic Neoplasm+6 more
Telix Pharmaceuticals (Innovations) Pty Limited 338
Not applicableStudy completedNCT04983459
What this trial is testing

PSMA PET/CT for Biochemical Recurrence Detection in Patients With Prostate Cancer

Who this might be right for
Prostatic NeoplasmsRecurrence
University Hospital, Brest 205
Next Page